Incidental MRI detection of BRCA1-related solitary peritoneal carcinoma during breast screening-A case report

Gynecologic Oncology

Volumn 107, Issue 1, 2007, Pages 136-139

  Hill, Kimberley A ^a   Rosen, Barry ^b   Shaw, Patricia ^c   Causer, Petrina A ^a   Warner, Ellen ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

BRCA1; MRI screening; Primary peritoneal carcinoma

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CASE REPORT; CYSTADENOMA; DISEASE FREE INTERVAL; FEMALE; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; LIVER TUMOR; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PERITONEUM CANCER; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA, PAPILLARY; BREAST NEOPLASMS; FALLOPIAN TUBES; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OVARIECTOMY; PERITONEAL NEOPLASMS;

EID: 34648814233     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.05.037     Document Type: Article

References (20)

1. Chen S., and Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol. 13 (2007) 1329-1333
2. Brose M.S., Rebbeck T.R., Calzone K.A., et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J. Natl. Cancer Inst. 94 (2002) 1365-1372
3. Satagopan J.M., Boyd J., Kauff N.D., et al. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2. Clin. Cancer Res. 8 (2002) 3776-3781
4. King M., Marks J.H., and Mandell J.B. Breast and ovarian risks due to inherited mutations in BRCA1 and BRCA2. Science 302 (2003) 643-646
5. Rebbeck T.R., Lynch H.T., Neuhausen S.L., et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346 (2002) 1616-1622
6. Finch A., Beiner M., Lubinski J., et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutations. JAMA 296 (2006) 185-192
7. Kauff N.D., Satagopan J.M., Robson M.E., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 346 (2002) 1609-1615
8. Finch A., Shaw P.A., Rosen B., et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol. Oncol. 100 (2005) 58-64
9. Olivier R.I., van Beurden M., Lubsen M.A.C., et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow up. Br. J. Cancer 90 (2004) 1492-1497
10. Powell C.B., Kenley E., Chen L., et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carries: role of serial sectioning in the diction of occult malignancy. J. Clin. Oncol. 23 (2005) 127-132
11. Levine D.A., Argenta P.A., Yee C.J., et al. Fallopian tube and primary peritoneal carcinoma associated with BRCA mutations. J. Clin. Oncol. 21 (2003) 4222-4227
12. Casey M.J., Synder C., Bewtra C., et al. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Gynecol. Oncol. 97 (2005) 457-467
13. Schore J.O., Muto M.G., Welch W.R., et al. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J. Natl. Cancer Inst. 90 (1998) 841-845
14. Fromm G.L., Gershenson D.M., and Silva E.G. Papillary serous carcinoma of the peritoneum. Obstet. Gynecol. 75 (1990) 89-95
15. Zhou J., Iwasa Y., Konishi I., et al. Papillary serous carcinoma of the peritoneum in women: A clinicopathologic and immunohistochemical study. Cancer 76 (1995) 7426-7436
16. Strnad C.M., Grosh W.W., Baxter J., et al. Peritoneal carcinomatosis of unknown primary site in women. Ann. Intern. Med. 111 (1989) 213-217
17. Dalrymple J.C., Bannatyne P., Russell P., et al. Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer 64 (1989) 110-115
18. Ransom D.T., Patel S.R., Kenney G.L., et al. Papillary serous carcinoma of the peritoneum: a review of 33 cases treated with cisplatin-based chemotherapy. Cancer 66 (1990) 1091-1094
19. Bloss J.D., Liao S.T., Buller R.E., et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol. Oncol. 50 (1993) 347-351
20. Piver M.S., Eltabbakh G.H., Hempling R.E., et al. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin/doxorubicin/cyclophosphamide or paclitaxel/cisplatin. Gynecol. Oncol. 67 (1997) 141-146